טוען...
Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients
BACKGROUND AND AIM: Coronavirus disease 2019 (COVID‐19) has attracted increasing worldwide attention. While diabetes is known to aggravate COVID‐19 severity, it is not known whether nondiabetic patients with metabolic dysfunction are also more prone to more severe disease. The association of metabol...
שמור ב:
| הוצא לאור ב: | J Gastroenterol Hepatol |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7280625/ https://ncbi.nlm.nih.gov/pubmed/32436622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jgh.15112 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|